Golestan University of Medical Sciences Repository

Genetic variations in cytochrome P450 2C9 and 2C19: A review

Marjani, A. (2016) Genetic variations in cytochrome P450 2C9 and 2C19: A review. Current Pharmacogenomics and Personalized Medicine, 14 (1). pp. 18-28.

Full text not available from this repository.

Abstract

DNA polymorphisms have an important role in the genes encoding. A number of cytochrome P450 (CYP) enzymes are leading to drug metabolism variation in different subjects. CYP2C9 and CYP2C19 metabolize many clinically important drugs. Inter-individual variability in drug metabolism may change drug reactions and variability in drug efficiency. Cytochrome P450 (CYPs) polymorphisms may show an important effect on drug metabolism, toxicity and hepatotoxicity. The most common clinical effects are associated with CYP2C19 and CYP2C9 mutants. Differences in genetic polymorphism of these cytochromic enzymes in inter-individual still remain unknown. This review article summarizes the most important polymorphisms of 2C9 and 2C19 diversity which is important for metabolism of some drugs and treatment of several diseases. Determining the pharmacokinetic effects of CYP2C19 and CYP2C9 genotypes may help physicians choose the optimal dosage of some drugs for the treatment and prevention of their side effects. Since different ethnic groups from all over the world use medications, it seems necessary to investigate the pharmacokinetic effects of CYP2C19 and CYP2C9 genotypes in different populations, due to drug consumption with optimal dosage in different ethnic groups. © 2016 Bentham Science Publishers.

Item Type: Article
Additional Information: cited By 0
Subjects: مقالات نمایه شده محققین دانشگاه در سایت ,Web of Science ,Scopus
Divisions: UNSPECIFIED
Depositing User: GOUMS
Date Deposited: 13 Jun 2017 05:35
Last Modified: 13 Jun 2017 05:35
URI: http://eprints.goums.ac.ir/id/eprint/4923

Actions (login required)

View Item View Item